Filing Details

Accession Number:
0000899243-19-019501
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-11 21:00:38
Reporting Period:
2019-07-10
Accepted Time:
2019-07-11 21:00:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1351288 Gw Pharmaceuticals Plc GWPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754145 A. William Waldegrave Sovereign House, Vision Park, Histon
Cambridge X0 CB24 9BZ
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-07-10 3,576 $0.00 3,576 No 4 M Direct
Ordinary Shares Disposition 2019-07-10 3,576 $15.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Options Disposition 2019-07-10 3,576 $0.00 3,576 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,164 2019-01-03 2028-01-03 No 4 M Direct
Footnotes
  1. Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
  2. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.25 U.S. Dollars as of July 10, 2019.
  3. Represented by ADSs. The sales reported were effected pursuant to a Rule 10b-5 trading plan adopted by the Reporting Person on May 10, 2019.
  4. The price reported in Column 4 is price per ordinary share converted from price per ADS.
  5. The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 10,740 ordinary shares vesting on January 3, 2021 and expiring on January 3, 2028. The correct vesting schedules for these securities are: 3,680 ordinary shares have vested on January 3, 2019, and the rest will vest equally on January 3, 2020 and January 3, 2021.